-
Spotlight: Deals in focus – Summer 2024
Welcome to our inaugural edition of Spotlight – Deals in focus.
-
Viewpoint: Summer 2024
Read our analysis of the UK’s listed markets for H1 2024, as we explore current market trends and what we expect from the future market’s position as we continue into H2 2024.
-
AIM – Hitting the sweet spot for European Green Transition plc
European Green Transition plc were one of few companies to float on AIM this year. Aiden Lavelle, CEO and Jack Kelly, CFO explain the reasons for their bold decision and why AIM hits the sweet spot for them.
-
New government update: Change to the non-dom regime
With the Labour Party winning the 2024 general election in July, the new government is making changes to some key areas of the proposed policies previously announced.
-
Insurer Update – Summer 2024
Welcome to our latest edition of Insurer Update.
-
Pillar Two: what it means for UK intermediate entities of US parented insurance groups
We explain why it is important for multinational entities (MNEs) to understand the interaction of Pillar Two and US tax principles – and how that affects UK intermediate entities.
-
Operational resilience: are you ready?
The growing threats of cyber attacks and operational risks against a complex geopolitical backdrop are sharpening the focus of regulators. We summarise what firms must do by the March IBS deadline.
-
Solvency UK: changes for small firms
What do the revised thresholds for Solvency II mean for firms? And what are the benefits of becoming a non-directive firm (NDF)?
-
UK GAAP: the latest updates for Carriers
The FRC published periodic changes to FRS 102 in March. So what do these changes mean for insurers?
-
Deal alert: Pathfinder Minerals plc
We have supported Pathfinder Minerals plc on their acquisition of Rome Resources Ltd.
-
Deal alert: Altona Rare Earths Plc
We are delighted to have supported Altona Rare Earths Plc in connection with the publication of a prospectus and issue of new shares to LSE.
-
Deals Review H1 2024
Read all about the transactions and the companies we supported in our Capital Markets Deals Review H1 2024.
